• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Cue Health

Layoffs in medtech: These companies recently reduced their workforce

December 6, 2024 By Sean Whooley

Medtech layoffs are picking up as 2024 draws to a close. Sean Whooley, Associate Editor, and Chris Newmarker, Editor-in-Chief The medical device industry is closing out the year with a fresh round of layoffs. At this point, MassDevice has reported on more than 22,000 medtech job cuts across the industry since mid-2022. (Have a tip […]

Filed Under: Business/Financial News, Featured, In-Depth Coverage, MassDevice Earnings Roundup, Special Content, Wall Street Beat Tagged With: 3m, Accuray, Acutus Medical, Akili Interactive Labs, Ambu, Baxter, BD, Better Therapeutics, Boston Scientific, Butterfly Network, Cala Health, Cook Medical, Cue Health, Dentsply Sirona, iCad Inc., ICU Medical, Illumina, Johnson & Johnson MedTech, LivaNova, Nevro Corp., Pear Therapeutics, Philips, Retractable Technologies, Siemens Healthineers, Surgalign, Surmodics, Titan Medical, Venus Concept, Verily, Vicarious Surgical, Zimmer Biomet

FDA revokes EUA for Cue Health COVID-19 tests

October 16, 2024 By Sean Whooley

The FDA today issued a notice classifying the recall of Cue Health COVID-19 tests as Class II and revoking the tests’ EUA. Earlier this year, the FDA said an inspection found that the company made changes to tests that previously garnered emergency use authorization (EUA) in 2020 and 2021. Cue Health also won FDA de novo clearance for its […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Health Technology, Recalls, Regulatory/Compliance Tagged With: Cue Health, FDA

Cue Health lays off remaining employees after FDA warning on COVID-19 tests

May 22, 2024 By Jim Hammerand

Cue Health (NASDAQ: HLTH) is laying off all of its remaining employees in the U.S. — including the company’s leadership — after the FDA warned that the device developer’s COVID-19 tests should not be used. As of May 1, San Diego-based Cue Health already told 191 employees they would lose their jobs in July. The […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, Health Technology Tagged With: coronavirus, COVID-19, Cue Health, FDA, Layoffs

FDA warns not to use Cue Health COVID-19 test kits

May 14, 2024 By Sean Whooley

The FDA has warned that home test users, caregivers and healthcare providers should not use Cue Health COVID-19 diagnostics. This warning extends to COVID-19 tests for home and over-the-counter (OTC) use as well as a test intended for patient care settings. According to the FDA, it issued the warning as a result of an increased […]

Filed Under: Diagnostics, Genomics/Molecular Diagnostics, Health Technology Tagged With: coronavirus, COVID-19, Cue Health

Cue Health wins FDA de novo authorization for home COVID-19 test

June 7, 2023 By Sean Whooley

Cue Health (Nasdaq:HLTH) announced that it received FDA de novo authorization for its Cue COVID-19 molecular test. San Diego-based Cue Health designed the test for both home and point-of-care use. Its authorization marks the first such nod for a home-use COVID-19 test, the company said. It also represents the first de novo authorization for any […]

Filed Under: Business/Financial News, Diagnostics, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Health Technology, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Cue Health, FDA

Cala Health, Cue Health have layoffs in California

May 22, 2023 By Sean Whooley

Cala Health and Cue Health (Nasdaq:HLTH) both recently filed with the state of California to confirm reductions in their workforces. The two companies are the latest to join the long list of medtech companies cutting employees amid a challenging time for the industry. To date, MassDevice has reported on more than 18,000 medtech employees who have been […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Health Technology, Neurological, Neuromodulation/Neurostimulation, News Well Tagged With: Cala Health, Cue Health, Personnel Moves

Cue Health submits RSV molecular test to FDA for de novo clearance

May 9, 2023 By Sean Whooley

Cue Health (Nasdaq:HLTH) announced today that it made a de novo submission to the FDA for clearance of its RSV molecular test. The submission aims to garner full clearance of the test for at-home and point-of-care use. According to Cue Health, no respiratory syncytial virus (RSV) tests exist on the market for home use. Pending […]

Filed Under: Business/Financial News, Diagnostics, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, News Well, Regulatory/Compliance, Respiratory Tagged With: Cue Health, FDA

Cue Health, Major League Baseball partner on COVID-19 testing

April 1, 2022 By Sean Whooley

Cue Health (Nasdaq:HLTH) and Major League Baseball (MLB) announced today that will expand on league-wide COVID-19 testing. Under a national partnership, Cue Health — MLB’s trusted at-home testing solution — will provide MLB clubs as well as the league office with its integrated care platform that includes the portable and reusable Cue Health monitoring system […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, Health Technology Tagged With: coronavirus, COVID-19, Cue Health

Cue Health launches direct-to-consumer virtual health platform

November 9, 2021 By Sean Whooley

Cue Health (NSDQ:HLTH) announced today that it will launch its direct-to-consumer virtual health program on Nov. 15, 2021. San Diego-based Cue Health’s virtual health platform includes what it says is a first-of-its kind molecular COVID-19 test through its new eCommerce site and in-app shop. The company said in a news release that it makes the […]

Filed Under: Big Data, Business/Financial News, Diagnostics, Digital Health, Electronic Medical Records (EMR), Featured, Genomics/Molecular Diagnostics, Health Technology, Software / IT Tagged With: Cue Health

MedTech 100 roundup: More growth ahead?

May 24, 2021 By Sean Whooley

A turgid month for the medtech industry might be drifting into the past after the past week indicated a slight turnaround as summer nears. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week at 107.74 points, marking a 1.4% rise from the 106.22-point mark set one […]

Filed Under: Business/Financial News, Funding Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: BD, coronavirus, COVID-19, Cue Health, DarioHealth Corp, DeviceTalks Weekly, Fractyl Laboratories, Giiant Pharma, Google, MedTech 100 Index, Memic Innovative Surgery, Teleflex

Cue Health raises $235M to support its over-the-counter, home-use diagnostics

May 14, 2021 By Sean Whooley

Healthcare technology company Cue Health announced that it closed a private financing round worth $235 million. Existing investors Johnson & Johnson Innovation — JJDC, Decheng Capital, CAVU Ventures, ACME Capital and more contributed to the financing, as did new investors Perceptive Advisors, MSD Capital and Koch Strategic Platforms, according to a news release. Morgan Stanley […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Funding Roundup, Genomics/Molecular Diagnostics, Health Technology Tagged With: coronavirus, COVID-19, Cue Health

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy